A carregar...
Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
Immediate-release (IR) formulation of linaclotide 290 μg improves abdominal pain and constipation (APC) in patients with irritable bowel syndrome (IBS) with constipation. Delayed-release (DR) formulations were developed on the premise that targeting the ileum (delayed-release formulation 1 [DR1]) or...
Na minha lista:
| Publicado no: | Am J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8279899/ https://ncbi.nlm.nih.gov/pubmed/33065589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000967 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|